Skip to main content

Advertisement

Table 2 The patients accepted postoperative adjuvant therapy in this study

From: Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study

No. Whether relapse DFS (mouths) Treatment Ki67 index (%)
1 No recurred 18 Octreotide 5
2 Recurred 22 Octreotide 5
3 Recurred 17 Octreotide 15
4 Recurred 9 Chemotherapy (gemcitabine) 5
5 Recurred 13 Octreotide 4
6 Recurred 72 Chemotherapy (gemcitabine) 3